Advisory Services Network’s SpringWorks Therapeutics SWTX Stock Holding History

Advisory Services Network’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,850	Closed	-$363K	–	1541
2021 Q4	$363K	Hold	5,850	–	–	0.01%	1015
2021 Q3	$371K	Hold	5,850	–	–	0.01%	998
2021 Q2	$482K	Hold	5,850	–	–	0.02%	897
2021 Q1	$430K	Hold	5,850	–	–	0.02%	891
2020 Q4	$424K	Hold	5,850	–	–	0.02%	803
2020 Q3	$279K	Buy	+5,850	New	+$249K	0.01%	856

Other funds holding SWTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Advisory Services Network's SWTX Position: Q1 2022 in Review

Advisory Services Network sold out of SpringWorks Therapeutics (SWTX) in Q1 2022, closing a stake of 5,850 shares — an estimated $363K sold.

Advisory Services Network first reported a position in SWTX in Q3 2020 and held it in 6 quarters. The position peaked at $482K in Q2 2021. 137 funds tracked by Wall St. Rank hold SWTX as of Q1 2022.

Advisory Services Network reported no remaining SpringWorks Therapeutics position as of Q1 2022 after selling out during the quarter.
Advisory Services Network sold 5,850 SpringWorks Therapeutics shares in Q1 2022, an estimated $363K.
Advisory Services Network first reported a position in SpringWorks Therapeutics in Q3 2020 and held it in 6 quarters.
Advisory Services Network's SpringWorks Therapeutics position peaked at $482K in Q2 2021.
137 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2022.

Based on Advisory Services Network's 13F filing for Q1 2022, filed 23 May 2022.